Novo Nordisk

A drug company based in Denmark. It sponsored the SELECT, LEADER and FLOW trials, and it is the applicant listed in the US regulatory records for Ozempic and Wegovy.

Also called Novo Nordisk A/S · NOVO

Organization
In this atlas

Overview

Technical summary

ROR 0435rc536. ClinicalTrials.gov lists Novo Nordisk A/S as lead sponsor of NCT03574597 (SELECT), NCT01179048 (LEADER) and NCT03819153 (FLOW), with sponsor class INDUSTRY. The openFDA application records for NDA209637 and NDA215256 list the applicant as NOVO.

Roles

Company

Sector

Industry

Record details

Record id: cardio:novo-nordisk
Content hash: 9fd86f8c1b09d73bcd2d6faf64f2d98cb637ee0e0041a83fd26d5c7da6614d51